Caxton Associates (New York)’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,389
Closed -$221K 578
2022
Q1
$221K Buy
+2,389
New +$221K 0.02% 393